118 related articles for article (PubMed ID: 16381170)
1. [HMGA proteins and their genes as a potential neoplastic biomarkers].
Balcerczak E; Balcerczak M; Mirowski M
Postepy Biochem; 2005; 51(3):261-9. PubMed ID: 16381170
[TBL] [Abstract][Full Text] [Related]
2. HMGA proteins as therapeutic drug targets.
Reeves R; Beckerbauer LM
Prog Cell Cycle Res; 2003; 5():279-86. PubMed ID: 14593722
[TBL] [Abstract][Full Text] [Related]
3. Differential HMGA expression and post-translational modifications in prostatic tumor cells.
Diana F; Di Bernardo J; Sgarra R; Tessari MA; Rustighi A; Fusco A; Giancotti V; Manfioletti G
Int J Oncol; 2005 Feb; 26(2):515-20. PubMed ID: 15645138
[TBL] [Abstract][Full Text] [Related]
4. HMGA and cancer.
Fedele M; Fusco A
Biochim Biophys Acta; 2010; 1799(1-2):48-54. PubMed ID: 20123067
[TBL] [Abstract][Full Text] [Related]
5. Critical role of HMGA proteins in cancer cell chemoresistance.
D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
[TBL] [Abstract][Full Text] [Related]
6. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A
Eur J Cancer; 2013 Mar; 49(5):1142-51. PubMed ID: 23149213
[TBL] [Abstract][Full Text] [Related]
7. Macroscopic differences in HMGA oncoproteins post-translational modifications: C-terminal phosphorylation of HMGA2 affects its DNA binding properties.
Sgarra R; Maurizio E; Zammitti S; Lo Sardo A; Giancotti V; Manfioletti G
J Proteome Res; 2009 Jun; 8(6):2978-89. PubMed ID: 19317492
[TBL] [Abstract][Full Text] [Related]
8. Roles of HMGA proteins in cancer.
Fusco A; Fedele M
Nat Rev Cancer; 2007 Dec; 7(12):899-910. PubMed ID: 18004397
[TBL] [Abstract][Full Text] [Related]
9. The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomas.
De Martino I; Visone R; Palmieri D; Cappabianca P; Chieffi P; Forzati F; Barbieri A; Kruhoffer M; Lombardi G; Fusco A; Fedele M
Endocr Relat Cancer; 2007 Sep; 14(3):875-86. PubMed ID: 17914116
[TBL] [Abstract][Full Text] [Related]
10. Interplay between HMGA and TP53 in cell cycle control along tumor progression.
Meireles Da Costa N; Palumbo A; De Martino M; Fusco A; Ribeiro Pinto LF; Nasciutti LE
Cell Mol Life Sci; 2021 Feb; 78(3):817-831. PubMed ID: 32920697
[TBL] [Abstract][Full Text] [Related]
11. The HMGA proteins: a myriad of functions (Review).
Cleynen I; Van de Ven WJ
Int J Oncol; 2008 Feb; 32(2):289-305. PubMed ID: 18202751
[TBL] [Abstract][Full Text] [Related]
12. Methylated genes as new cancer biomarkers.
Duffy MJ; Napieralski R; Martens JW; Span PN; Spyratos F; Sweep FC; Brunner N; Foekens JA; Schmitt M;
Eur J Cancer; 2009 Feb; 45(3):335-46. PubMed ID: 19138839
[TBL] [Abstract][Full Text] [Related]
13. CD200: a putative therapeutic target in cancer.
Moreaux J; Veyrune JL; Reme T; De Vos J; Klein B
Biochem Biophys Res Commun; 2008 Feb; 366(1):117-22. PubMed ID: 18060862
[TBL] [Abstract][Full Text] [Related]
14. Arabidopsis chromatin-associated HMGA and HMGB use different nuclear targeting signals and display highly dynamic localization within the nucleus.
Launholt D; Merkle T; Houben A; Schulz A; Grasser KD
Plant Cell; 2006 Nov; 18(11):2904-18. PubMed ID: 17114349
[TBL] [Abstract][Full Text] [Related]
15. High Mobility Group A (HMGA) proteins: Molecular instigators of breast cancer onset and progression.
Sgarra R; Pegoraro S; Ros G; Penzo C; Chiefari E; Foti D; Brunetti A; Manfioletti G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):216-229. PubMed ID: 29518471
[TBL] [Abstract][Full Text] [Related]
16. Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.
Wu K; Quan Z; Weng Z; Li F; Zhang Y; Yao X; Chen Y; Budman D; Goldberg ID; Shi YE
Breast Cancer Res Treat; 2007 Mar; 101(3):259-67. PubMed ID: 16821081
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
18. Regulation of p53R2 and its role as potential target for cancer therapy.
Wang X; Zhenchuk A; Wiman KG; Albertioni F
Cancer Lett; 2009 Apr; 276(1):1-7. PubMed ID: 18760875
[TBL] [Abstract][Full Text] [Related]
19. Architectural factor HMGA induces promoter bending and recruits C/EBP and GATA during silkmoth chorion gene regulation.
Papantonis A; Vanden Broeck J; Lecanidou R
Biochem J; 2008 Nov; 416(1):85-97. PubMed ID: 18636971
[TBL] [Abstract][Full Text] [Related]
20. HMGA and Cancer: A Review on Patent Literatures.
De Martino M; Fusco A; Esposito F
Recent Pat Anticancer Drug Discov; 2019; 14(3):258-267. PubMed ID: 31538905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
